Related Experiment Videos
Microbial factors leading to recurrent upper respiratory tract infections
1Department of Pediatrics, Georgetown University, Washington, DC, USA.
Abstract:
The treatment or prophylaxis of upper respiratory tract infections such as otitis media, sinusitis and tonsillitis with penicillins can generate bacterial resistance caused by production of beta-lactamase or changes in the penicillin-binding proteins. This resistance can spread in the community even to untreated individuals. The prevalence of resistant organisms tends to increase in the winter months. Beta-lactamase-producing bacteria may interfere with the eradication of penicillin-susceptible organisms and may account for substantial numbers of therapeutic failures among cases of otitis media, sinusitis and tonsillitis. The presence of normal flora that possess interfering capabilities against potential pathogens is beneficial to the host. Such flora may enhance recovery and prevent infections of the tonsils by group A beta-hemolytic streptococci. Therapeutic use of antimicrobial agents that preserve the normal flora but overcome penicillin-susceptible or -resistant pathogens may enhance recovery from upper respiratory tract infections.
Insights
Penicillin use for upper respiratory infections can cause bacterial resistance, spreading to others. New treatments preserving normal flora may improve recovery and prevent future infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Penicillin treatment for upper respiratory tract infections (URTIs) like otitis media, sinusitis, and tonsillitis can lead to bacterial resistance.
- Mechanisms of resistance include beta-lactamase production and alterations in penicillin-binding proteins, contributing to treatment failures.
- Resistant organisms can spread within the community, increasing prevalence, particularly during winter months.
Purpose of the Study:
- To investigate the impact of bacterial resistance on URTI treatment outcomes.
- To explore the role of normal flora in combating pathogens and enhancing recovery.
- To identify therapeutic strategies that preserve normal flora while effectively treating infections.
Main Methods:
- Review of existing literature on penicillin resistance in URTIs.
- Analysis of the mechanisms of bacterial resistance and their clinical implications.
- Evaluation of the protective role of normal microbial flora in the respiratory tract.
Main Results:
- Beta-lactamase-producing bacteria can hinder the eradication of susceptible organisms, leading to therapeutic failures.
- Community spread of resistance affects both treated and untreated individuals.
- Normal flora can provide a beneficial defense against pathogens, aiding recovery and preventing secondary infections.
Conclusions:
- Antimicrobial agents that preserve normal flora while targeting resistant pathogens offer a promising approach for URTI treatment.
- Maintaining a healthy microbiome is crucial for preventing and managing respiratory tract infections.
- Further research into selective antimicrobial therapies is warranted to combat resistance and improve patient outcomes.